Carla Balch leads the healthcare software and services division of Aranscia, which also owns AccessDx Laboratory. Previously, she was founder and CEO of Spesana.
Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction.
Molecular diagnostics companies have laid the foundation for nothing short of a revolution in cancer care — it’s time for the medtech sector to develop tools to make genomic testing accessible to the masses.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.